White & Case secures $405M jury win for Regeneron in antitrust case, with Amgen found liable for anti-competitive bundling ...

Suzy Katz's knee pain was so bad that she had trouble walking long distances. For years, it was blamed on Lyme disease, ...

Families report devastating outcomes following Librela injections for dogs, citing paralysis and death. Meanwhile, Zoetis maintains side effects are rare.

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.